This course will provide a state-of-the-art update on the pathophysiology, clinical progression and course, assessment and management of COPD. It will also shed light on recent and ongoing clinical trials and outline evidence-based pharmacological and non-pharmacological management strategies. In addition, interventions to prevent of COPD exacerbation will be discussed. Attendees will be updated on the evolving knowledge on COPD phenotypes, endotypes and biomarkers as well as recent advances in understanding the genetic aspect of this disease. Finally, the course will also outline unmet and future research needs.
CME credits and/or Certificates of Completion are not provided for this session.
1- Identify challenges associated with the contemporary assessment and management of chronic obstructive pulmonary disease (COPD) based on evidence-based clinical practice guidelines recommendations
2- Learn new findings and gain competence in providing pharmacological and non-pharmacological management of COPD
3- Recognize unmet needs for future research in the field
Ravi Kalhan, MD, MS. : Disease Progression of COPD: What Have We Learned from Clinical and Cohort Studies?
Peter J. Barnes, MD, DSc, ATSF: Novel Insights on the Immunopathology of COPD
Craig P. Hersh, MD, MPH, ATSF.: Insights from COPD Genetics
Yvonne J. Huang, MD, ATSF.: The Role of Microbiome in COPD: Evolving Knowledge
Victor Kim, MD, ATSF.: New Concepts in the Diagnosis and Management of Chronic Bronchitis
Dave Singh, MD, NP. : Biomarkers for COPD: Are We There Yet?
George R. Washko, MD.: Role of Radiologic Imaging in COPD
Jadwiga A. Wedzicha, MD, ATSF. : Prevention of COPD Exacerbations
Gerard J. Criner, MD, ATSF. : GOLD 2021: An Update
Frank C. Sciurba, MD. : Bronchoscopic Interventions in COPD
Nicholas Hart, MD: Non-Invasive Ventilation in COPD
Anne E. Holland, PhD: Pulmonary Rehabilitation at Home: Can It Be Done?
Jessica M. Bon, MD, MS, ATSF: Assessment and Management of Comorbidities in COPD
Roberto Benzo, MD, MSc: Promoting Self-Management for a Behavior Change in COPD
Nicola A. Hanania, MD, MS, ATSF: Bronchodilators in COPD: An Update
Mark T. Dransfield, MD: Inhaled Steroids in COPD: Friend or Foe?
Ian D. Pavord, MD: Novel Pharmacologic Targets for COPD
You can save 20% today by joining the ATS. Join more than 16,000 healthcare providers and researchers as a member of the American Thoracic Society today. As an ATS member, you’ll gain access to cutting-edge science, collaboration opportunities, discounts on the annual ATS International Conference, and resources to share with patients. The ATS offers multiple ways to get involved, from Assembly membership to in-person networking opportunities, as well as an online community offered through DocMatter. Join the ATS Today!